HRP20070574T3 - Antimycobacterial pharmaceutical composition comprising an antitubercular drug - Google Patents

Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Info

Publication number
HRP20070574T3
HRP20070574T3 HR20070574T HRP20070574T HRP20070574T3 HR P20070574 T3 HRP20070574 T3 HR P20070574T3 HR 20070574 T HR20070574 T HR 20070574T HR P20070574 T HRP20070574 T HR P20070574T HR P20070574 T3 HRP20070574 T3 HR P20070574T3
Authority
HR
Croatia
Prior art keywords
pharmaceutical composition
antimycobacterial
antitubercular drug
antimycobacterial pharmaceutical
methyl
Prior art date
Application number
HR20070574T
Other languages
English (en)
Croatian (hr)
Inventor
Kumar Arora Sudershan
Sinha Neelima
Sinha Rakesh
Shankar Upadhyaya Ram
Original Assignee
Lupin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Limited filed Critical Lupin Limited
Publication of HRP20070574T3 publication Critical patent/HRP20070574T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20070574T 2004-05-12 2004-08-27 Antimycobacterial pharmaceutical composition comprising an antitubercular drug HRP20070574T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/844,992 US7491721B2 (en) 2004-05-12 2004-05-12 Antimycobacterial pharmaceutical composition
PCT/IN2004/000266 WO2005107809A2 (fr) 2004-05-12 2004-08-27 Composition pharmaceutique antimycobacterienne

Publications (1)

Publication Number Publication Date
HRP20070574T3 true HRP20070574T3 (en) 2008-01-31

Family

ID=34960626

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070574T HRP20070574T3 (en) 2004-05-12 2004-08-27 Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Country Status (44)

Country Link
US (1) US7491721B2 (fr)
EP (1) EP1750765B1 (fr)
JP (1) JP2007537242A (fr)
KR (1) KR100854309B1 (fr)
CN (1) CN1956732B (fr)
AP (1) AP1994A (fr)
AR (1) AR048948A1 (fr)
AT (1) ATE373488T1 (fr)
AU (1) AU2004319259A1 (fr)
BR (1) BRPI0418770A (fr)
CA (1) CA2566440C (fr)
CR (1) CR8748A (fr)
DE (1) DE602004009113T2 (fr)
DK (1) DK1750765T3 (fr)
DO (1) DOP2005000085A (fr)
EA (1) EA009694B1 (fr)
EC (1) ECSP066965A (fr)
ES (1) ES2294577T3 (fr)
GE (1) GEP20094805B (fr)
HN (1) HN2005000210A (fr)
HR (1) HRP20070574T3 (fr)
IL (1) IL178858A (fr)
IS (1) IS8559A (fr)
JO (1) JO2471B1 (fr)
MA (1) MA28603B1 (fr)
MX (1) MXPA06012984A (fr)
MY (1) MY139187A (fr)
NI (1) NI200600270A (fr)
NO (1) NO20065725L (fr)
NZ (1) NZ550892A (fr)
PA (1) PA8633001A1 (fr)
PE (1) PE20060353A1 (fr)
PL (1) PL1750765T3 (fr)
PT (1) PT1750765E (fr)
RS (1) RS20060624A (fr)
SA (1) SA05260130B1 (fr)
SI (1) SI1750765T1 (fr)
SM (1) SM200500011A (fr)
SV (1) SV2006002109A (fr)
TN (1) TNSN06349A1 (fr)
UA (1) UA82782C2 (fr)
UY (1) UY28893A1 (fr)
WO (1) WO2005107809A2 (fr)
ZA (1) ZA200608843B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006233943A1 (en) * 2005-04-11 2006-10-19 Lupin Limited Preparation of (2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)) pyrrole derivatives
JP5339840B2 (ja) * 2008-10-02 2013-11-13 公益財団法人微生物化学研究会 抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) * 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
US20110065723A1 (en) * 2009-09-11 2011-03-17 Vertex Pharmaceuticals Incorporated Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]-n-[3-(4-pyridyl)-1-[2-(4-pyridyl)ethyl]propyl]propanamide and uses thereof
HUP1000033A2 (en) * 2010-01-21 2011-07-28 Uratim Kft Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) * 2021-10-20 2022-11-03 순천향대학교 산학협력단 신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
CN117045657B (zh) * 2022-05-12 2026-05-26 广州嘉越医药科技有限公司 一种药物组合及其应用
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same
CN118743705B (zh) * 2024-08-12 2024-11-15 深圳大学 药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227383A (en) * 1991-06-14 1993-07-13 The University Of Mississippi Compounds and compositions useful as antifungal and antimycobacterial agents
MXPA05003022A (es) * 2002-09-20 2005-05-27 Lupin Ltd Nuevos compuestos antimicobacterianos.

Also Published As

Publication number Publication date
SM200500011B (it) 2005-11-16
KR20070007920A (ko) 2007-01-16
AR048948A1 (es) 2006-06-14
KR100854309B1 (ko) 2008-08-26
EA200601952A1 (ru) 2007-02-27
NZ550892A (en) 2009-12-24
ECSP066965A (es) 2006-12-20
HN2005000210A (es) 2009-03-17
ZA200608843B (en) 2008-07-30
AP1994A (en) 2009-04-09
WO2005107809A8 (fr) 2006-05-18
MXPA06012984A (es) 2007-04-23
DE602004009113D1 (de) 2007-10-31
DK1750765T3 (da) 2008-01-28
JO2471B1 (en) 2009-01-20
PT1750765E (pt) 2007-12-31
IS8559A (is) 2006-10-26
BRPI0418770A (pt) 2007-10-09
EP1750765B1 (fr) 2007-09-19
WO2005107809A2 (fr) 2005-11-17
DOP2005000085A (es) 2007-01-15
JP2007537242A (ja) 2007-12-20
RS20060624A (sr) 2008-09-29
UY28893A1 (es) 2005-12-30
IL178858A0 (en) 2007-03-08
UA82782C2 (uk) 2008-05-12
MY139187A (en) 2009-08-28
AU2004319259A1 (en) 2005-11-17
PA8633001A1 (es) 2006-12-07
SM200500011A (it) 2005-11-16
MA28603B1 (fr) 2007-05-02
ATE373488T1 (de) 2007-10-15
WO2005107809A3 (fr) 2006-01-26
US7491721B2 (en) 2009-02-17
ES2294577T3 (es) 2008-04-01
CR8748A (es) 2008-06-02
CA2566440A1 (fr) 2005-11-17
CN1956732B (zh) 2010-04-28
HK1098962A1 (en) 2007-08-03
CA2566440C (fr) 2009-08-04
EP1750765A2 (fr) 2007-02-14
PL1750765T3 (pl) 2008-02-29
PE20060353A1 (es) 2006-07-08
SA05260130B1 (ar) 2008-05-04
TNSN06349A1 (en) 2008-02-22
DE602004009113T2 (de) 2008-06-19
SV2006002109A (es) 2006-04-18
AP2006003807A0 (en) 2006-12-31
SI1750765T1 (sl) 2008-04-30
NO20065725L (no) 2006-12-12
IL178858A (en) 2010-06-16
EA009694B1 (ru) 2008-02-28
CN1956732A (zh) 2007-05-02
GEP20094805B (en) 2009-10-26
US20050256128A1 (en) 2005-11-17
NI200600270A (es) 2007-12-11

Similar Documents

Publication Publication Date Title
AR025055A1 (es) Composiciones farmaceuticas
NO20043913L (no) Blandinger med modifisert frigjoring av i det minste en form av tramadol
MXPA05012248A (es) Fenil quinolinas y su uso como moduladores del receptor de estrogeno.
TR200200795T2 (tr) 5-HT1B antagonistleri olarak piperazin türevleri
DK1897546T3 (da) Kombinerede sammensætninger omfattende (E)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s]-3,5-dihydroxyhept-6-enoinsyre
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
PH12021550687A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
ATE495187T1 (de) Dalda-analoge und ihre verwendung
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
SE0402762D0 (sv) Indazole sulphonamide derivatives
DK1736158T3 (da) Anvendel af 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazin samt de fysiologiske acceptable salte deraf
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
UY27416A1 (es) Uso de bibn4096 en combinación con otros fármacos antimigranosos para el tratamiento de migrana
GEP20094805B (en) Antimycobacterial pharmaceutical composition
BR0306923A (pt) Composição farmacêutica para regeneração de tecidos hepáticos para tratamento de cirrose do fìgado uso de 5-(2-pirazinil) -4-metil-1,2-ditiol-3-tiona
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
BRPI0409379A (pt) combinações de paroxetina e 1-(r)-(3-,5-bis-trifluormetil-fenil)-etil] metilamida do ácido (s)-(4-flúor-2-metil-fenil)-piperazina-1-carboxìlico para tratamento de depressão e/ou ansiedade
EA200702386A1 (ru) Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
MXPA05010135A (es) Nuevos derivados de oxazol, procedimiento para su fabricacion y uso como agentes farmaceuticos.
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
TW200626591A (en) Amide derivatives, their manufacture and use as pharmaceutical agents
DE60310896D1 (de) PHARMAZEUTISCHE ZUBEREITUNGEN ENTHALTEND NANOPARTIKEL VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANSULPHONYL-PHENYL)-PYRAZOLOi1,5-BöPYRIDAZIN